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The hitherto unknown (±)-4-methoxydecanoic acid was synthesized in six steps and in 25% overall
yield starting from commercially available 4-penten-1-ol. The title compound demonstrated
seventeen fold higher antifungal activity (MIC = 1.5 mM) against Candida albicans ATCC 60193
and Cryptococcus. neoformans ATCC 66031 when compared to unsubstituted n-decanoic acid. Our
results demonstrate that Mid-chain methoxylation appears to be a viable strategy for increasing the
fungitoxicity of fatty acids.
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The (±)-4-hydroxydecanoic acid is an elusive fatty acid to isolate from either a natural or
synthetic source because of its tendency to easily cyclize to the well known γ-decalactone.1 In
fact, the spectral data for 4-hydroxydecanoic acid was first reported in 1996 by G. Feron and
collaborators, attesting to the difficulty of isolating the pure hydroxylated fatty acid from the
γ-decalactone.1 The γ-decalactone is an important compound for the aroma and food industries
since the compound imparts a peach-apricot flavor to foods2–3 and is also responsible for the
fruity flower odor of gardenia perfumes.1 The γ-decalactone has also been used in <5 ppm
concentrations in a selected number of cigarette brands.4
There are just a few scattered reports on the toxicity of (±)-4-hydroxydecanoic acid but it has
been reported that the presence of a hydroxyl group in the acyl chain greatly decreases toxicity.
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However, the γ-decalactone has been reported to have higher antibacterial activity than (±)-4hydroxydecanoic acid since it inhibits the growth of some bacteria such as Bacillus subtilis
and some fungi such as Fusarium oxysporum and Trichothecium roseum at concentrations
between 0.1 and 0.7 mM.1 It should also be noted here that the 3-(R)-hydroxydecanoic acid
has been isolated from Lactobacillus plantarum and displayed considerable antifungal activity
(MIC = 10–100 µg/mL) against different molds and yeasts.5
We have previously shown that α-methoxylation increases the antifungal activity of fatty acids,
6–7 but nothing is known as to the effect of mid-chain methoxylation on the antifungal activity
of these compounds. We envisioned that a compound such as the (±)-4-methoxydecanoic acid
(1) could be a good starting template to study such an effect. In addition, we were expecting
this methoxylated fatty acid to be more fungitoxic than the corresponding compounds,
unsubstituted n-decanoic acid (capric acid) or isolated (±)-4-hydroxydecanoic acid. The choice
of a 10-carbon chain length for this study is justified by the fact that capric acid kills Candida
albicans at 10 mM by the postulated mechanism of the fungal plasma membrane disintegration
while other saturated fatty acids are not effective.8
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Furthermore, unlike (±)-4-hydroxydecanoic acid, (±)-4-methoxydecanoic acid (1) cannot be
cyclized to the corresponding γ-lactone thus allowing the facile study of its fungitoxicity. This
investigation was also designed to determine whether mid-chain methoxylation is a viable
substitution to α-methoxylation for enhancing the antifungal activity of fatty acids such as
capric acid. Previous studies by our group with the (±)-2-methoxydecanoic acid has shown
that the 2-OMe-10:0 acid is only 1.5 fold more fungitoxic than capric acid (10:0) against C.
albicans (ATCC 14053). However, against C. neoformans (ATCC 66031) the 2-OMe-10:0
acid was not more antifungal than capric acid.6
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Our six-step synthesis started with the protection of the primary alcohol of commercially
available 4-penten-1-ol (2) with dihydropyran (DHP) and catalytic amounts of ptoluenesulfonic acid (PTSA) in CHCl3 at rt for 5h to afford the 1-[(tetrahydropyran-2-yl)
oxy]-2-pentene in an 88% yield (Scheme 1). The double bond was effectively epoxidized in
the presence of magnesium monoperoxyphthalate (MMPP) in EtOH as solvent for 48 h, to
yield the 4,5-epoxy-1-[(tetrahydropyran-2-yl)oxy]pentane (3) in 89% yield after purification
of the crude product using silica gel column chromatography (60–200 mesh) and eluting with
hexane/diethyl ether (8:2). MMPP turned out to be more efficient than the classical mchloroperoxybenzoic acid (m-CPBA) in epoxidizing these alkenes, since the latter reagent only
afforded moderate to low yields even after long reaction times. The THP protected epoxide
3 was then opened with 1-pentylmagnesium bromide assisted by catalytic amounts of copper
(I) chloride in THF at a reaction temperature range of −78°C to −30°C, which afforded the
desired 4-hydroxy-1-[(tetrahydropyran-2-yl)oxy]decane (4) in an 81% yield after silica gel
(60–200 mesh) column chromatographic purification. The free hydroxyl group in 4 was then
readily methylated with methyl iodide in the presence of sodium hydride in THF, which
afforded the 4-methoxy-1-[(tetrahydropyran-2-yl)oxy]decane (5) in an 88% yield.
Deprotection of the primary alcohol was effectively accomplished with PTSA in CHCl3 at 45°
C for 2h, which afforded the (±)-4-methoxydecan-1-ol in a 73% yield (Scheme 1). Final
oxidation to the acid was accomplished by reaction of the alcohol with pyridinium dichromate
(PDC) in DMF for 24h, which resulted in a 63% yield of 1.9 The overall yield for this six step
synthesis was 25%.
The most significant absorption in the NMR spectrum of 1 was observed for the carbons and
hydrogens bearing the methoxy functionality. For example, the methoxy protons resonated at
δ 3.32 ppm and the methoxy carbon was observed at δ 56.5 ppm, while the methine hydrogen
(CHOCH3) resonated at δ 3.20 ppm and the methine carbon (CHOCH3) at δ 79.9 ppm.
These 1H NMR and 13C NMR displacements seem to be characteristic for saturated mid-chain

Tetrahedron Lett. Author manuscript; available in PMC 2010 October 14.

Carballeira et al.

Page 3

NIH-PA Author Manuscript

methoxylated fatty acids and useful as a future reference for other similar analogs. It is also
interesting to mention that in the 70 eV electron impact (EI) mass spectrum of 1 the typical
McLafferty rearrangement of fatty acids at m/z = 60 was greatly reduced (1% relative
abundance) by the presence of the methoxy functionality at C-4. In the mass spectrum of 1 the
α fragmentation at both sides of the methoxylated carbon predominated, but the fragments
containing the carboxyl end (at m/z =117 corresponding to C5H903+ and at m/z = 85
corresponding to C4H502+) were the most abundant.
The antifungal activity of 1 was determined against a fluconazole-resistant strain of Candida
albicans (ATCC 60193) and against Cryptococcus neoformans (ATCC 66031) following our
previously published protocol (Table 1).6–7 n-Decanoic acid was also tested as a control. As
can be seen from the data in Table 1 the (±)-4-methoxydecanoic acid (1) was approximately
seventeen fold more antifungal against both fungal strains (MIC = 1,457 µM) when compared
to n-decanoic acid (MIC = 25,478 µM). Therefore, the antifungal results clearly show that C-4
methoxylation increased the antifungal activity of the parent n-decanoic acid. In fact, for ndecanoic acid C-4 methoxy substitution seems to be more effective than C-2 methoxy
substitution in increasing the antifungal activity of n-decanoic acid.6
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As to the reasons for the better antifungal activity of 1 over that of n-decanoic acid we can only
speculate at this stage and more mechanistic studies are required. The addition of the C-4
methoxy functionality possibly makes the fatty acid more soluble than unsubstituted ndecanoic acid thus facilitating its interaction with the target sites. In addition, based on the
previously published antifungal mechanism of decanoic acid8 we can also speculate that acid
1 seems to be able to more efficiently disrupt the fungal membranes due to the mid-chain
methoxy substitution. Moreover, the title compound 1 may also inhibit fatty acid biosynthesis
within the fungi interacting with some key enzymes. In summary, our results clearly
demonstrate that mid-chain methoxylated fatty acids are valuable compounds that can be
optimized for developing more potent antifungal agents and thus merit further scrutiny in the
search for better antifungal analogs.
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i) DHP/PTSA,CHCl3, rt, 5h, 88%; ii) MMPP/EtOH, 48h, 89%; iii) CH3(CH2)3CH2MgBr, Cu
(I) / THF, −78°C to −30°C, 81%; iv) NaH/CH3I, THF, 0°C to rt, 2h, 88%; v) PTSA, CHCl3,
45°C, 2h, 73%; vi) PDC/DMF, 24h, 63%.
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Antifungal activity (MIC values, µM) against Candida albicans (SDB) and Cryptococcus neoformans (SDB) at
35–37°C after 24–48ha.
Compound

C. albicans
ATCC 60193

C. neoformans
ATCC 66031

(±)-4-methoxydecanoic acid (1)

1457

1457

Decanoic acid

25478

25478

Fluconazole

>500

<0.9

Amphotericin B

<0.3

<0.3

>5000

>5000

DMSO
a

The results are the average of three separate experiments. The upper limit of the standard error of the mean (SEM) was ± 10%.
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